Welcome, please sign in
Follow DJO on Facebook Follow DJO on Twitter
Grand Rounds
  Most Recent Cases
  Dates of Case
  Type of Case
  Submit a Grand Round.
  Register with DJO to receive personalized updates.

If you're already a
member, please sign in.
A 54-year-old man with bilateral symmetrical circular corneal opacities
Digital Journal of Ophthalmology 2020
Volume 26, Number 2
June 21, 2020
DOI: 10.5693/djo.03.2019.12.001
Printer Friendly

Download PDF



Colm McAlinden, MD, MB BCh, BSc (Hons), MSc, PhD, MRCOphth | Department of Ophthalmology, Princess of Wales Hospital, Bridgend, United Kingdom
Christopher P. R. Williams, BSc (Hons), MB BCh (Hons), MRCP, FRCOphth | Department of Ophthalmology, Princess of Wales Hospital, Bridgend, United Kingdom



References
1. Almeida R, Ruão M, Almeida I, Rodrigues FD, Costa-Ferreira C, Chibante-Pedro J. Bilateral ring-shaped corneal opacity: case report and review of the literature. Vis Pan-Am 2016;15:61-2.
2. Ascher KW. Ungewöhnliche Hornhautringe [Unusual corneal ring]. Dtsch Ophthal Ges 1963;65:44-6.
3. Roberts WH, Wolter JR. Ocular chrysiasis. AMA Arch Ophthalmol 1956;56:48-52.
4. Spencer WH, Garron LK, Contreras F, Hayes TL, Lai C. Endogenous and exogenous ocular and systemic silver deposition. Trans Ophthalmol Soc U K 1980;100:171-8.
5. Melles GR, de Sera JP, Eggink CA, Cruysberg JR, Binder PS. Bilateral, anterior stromal ring opacity of the cornea. Br J Ophthalmol 1998;82:522-5.
6. Patel DV. Systemic associations of corneal deposits: a review and photographic guide. Clin Exp Ophthalmol 2017;45:14-23.
7. Weiss JS, Moller HU, Aldave AJ, et al. IC3D classification of corneal dystrophies—edition 2. Cornea 2015;34:117-59.
8. Miller KH, Green WR, Stark WJ, Wells HA, Mendelsohn G, Kanhofer H. Immunoprotein deposition in the cornea. Ophthalmology 1980;87:944-50.
9. Robaei D, Carnt N, Minassian DC, Dart JK. Therapeutic and optical keratoplasty in the management of Acanthamoeba keratitis: risk factors, outcomes, and summary of the literature. Ophthalmology 2015;122:17-24.
10. Dart JK, Saw VP, Kilvington S. Acanthamoeba keratitis: diagnosis and treatment update 2009. Am J Ophthalmol 2009;148:487-99 e2.
11. Denniston AKO, Murray PI. Oxford Handbook of Ophthalmology. 4th ed. Oxford: Oxford University Press; 2018.
12. Jackson TL. Moorfields Manual of Ophthalmology. 2nd ed. New Delhi: JP Medical Ltd; 2014.
13. Austin A, Lietman T, Rose-Nussbaumer J. Update on the management of infectious keratitis. Ophthalmology 2017;124:1678-89.
14. Tsatsos M, MacGregor C, Athanasiadis I, Moschos MM, Hossain P, Anderson D. Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents. Clin Exp Ophthalmol 2016;44:824-37.
15. Bowling B. Kanski’s Clinical ophthalmology: a systematic approach. 8th ed. Philadelphia: Elsevier; 2016.
16. Knickelbein JE, Hendricks RL, Charukamnoetkanok P. Management of herpes simplex virus stromal keratitis: an evidence-based review. Surv Ophthalmol 2009;54:226-34.
17. Kaufman HE, Haw WH. Ganciclovir ophthalmic gel 0.15%: safety and efficacy of a new treatment for herpes simplex keratitis. Curr Eye Res 2012;37:654-60.
18. Calvo CM, Sikder S, Mamalis N, Mifflin MD. Linear interstitial keratitis: a distinct clinical entity revisited. Cornea 2012;31:1500-503.
19. Knox CM, Holsclaw DS. Interstitial keratitis. Int Ophthalmol Clin 1998;38:183-95.
20. Kauffmann DJ, Wormser GP. Ocular Lyme disease: case report and review of the literature. Br J Ophthalmol 1990;74:325-7.
21. Wessely K. About anaphylactic phenomena of the cornea. München Med Wehascher. 1911;58:1713.
22. Morawiecki J. Antigen-antibody precipitation phenomena in the living cornea. Ophthalologica 1956;132:236-43.
23. Qiao GL, O’Donnell H, Yeung SN, Iovieno A. Case of bilateral Wessely rings in a contact lens wearer. Can J Ophthalmol 2019;54:e182-e3.
24. Orsoni JG, Zavota L, Pellistri I, Piazza F, Cimino L. Cogan syndrome. Cornea 2002;21:356-9.
25. Espinoza GM, Prost A. Cogan’s syndrome and other ocular vasculitides. Curr Rheumatol Rep 2015;17:24.
26. Iliescu DA, Timaru CM, Batras M, De Simone A, Stefan C. Cogan’s Syndrome. Rom J Ophthalmol 2015;59:6-13.
27. Kessel A, Vadasz Z, Toubi E. Cogan syndrome—pathogenesis, clinical variants and treatment approaches. Autoimmun Rev 2014;13:351-4.
28. Mohsenin A, Huang JJ. Ocular manifestations of systemic inflammatory diseases. Conn Med 2012;76:533-44.
29. Greco A, Gallo A, Fusconi M, et al. Cogan’s syndrome: an autoimmune inner ear disease. Autoimmun Rev 2013;12:396-400.
30. Kincaid MC, Green WR, Hoover RE, Schenck PH. Ocular chrysiasis. Arch Ophthalmol 1982;100:1791-4.
31. McCormick SA, DiBartolomeo AG, Raju VK, Schwab IR. Ocular chrysiasis. Ophthalmology 1985;92:1432-5.
32. Loewenstein A. Argyrosis of Conjunctiva, Cornea and Tear-Sac. Br J Ophthalmol 1941;25:360-69.
33. Wilkes JW. Argyrosis of the cornea and conjunctiva. J Tn State Med Assoc 1953;46:11-3.
34. Moss AP, Sugar A, Hargett NA, Atkin A, Wolkstein M, Rosenman KD. The ocular manifestations and functional effects of occupational argyrosis. Arch Ophthalmol 1979;97:906-8.
35. Tendler I, Pulitzer MP, Roggli V, Abramson DH, Marr BP. Ocular argyrosis mimicking conjunctival melanoma. Cornea 2017;36:747-8.
36. Tso MO, Fine BS, Thorpe HE. Kayser-Fleischer ring and associated cataract in Wilson’s disease. Am J Ophthalmol 1975;79:479-88.
37. Herron BE. Wilson’s disease (hepatolenticular degeneration). Ophthalmic Semin 1976;1:63-9.
38. Ryan A, Nevitt SJ, Tuohy O, Cook P. Biomarkers for diagnosis of Wilson’s disease. Cochrane Database Syst Rev 2019;2019:
39. Poujois A, Woimant F. Wilson’s disease: A 2017 update. Clin Res Hepatol Gastroenterol 2018;42:512-20.
40. Naik MP, Sethi HS, Dabas S. Ocular cystinosis: Rarity redefined. Indian J Ophthalmol 2019;67:1158-9.
41. Biswas S, Gaviria M, Malheiro L, Marques JP, Giordano V, Liang H. Latest clinical approaches in the ocular management of cystinosis: a review of current practice and opinion from the Ophthalmology Cystinosis Forum. Ophthalmol Ther 2018;7:307-22.
42. Del Longo A, Piozzi E, Schweizer F. Ocular features in mucopolysaccharidosis: diagnosis and treatment. Ital J Pediatr 2018;44:125.
43. Sornalingam K, Javed A, Aslam T, Sergouniotis P, Jones S, Ghosh A, Ashworth J. Variability in the ocular phenotype in mucopolysaccharidosis. Br J Ophthalmol 2019;103:504-10.
44. Sivley MD, Benjamin WJ. Fabry keratopathy: manifestations and changes over time. Br J Ophthalmol 2019 Oct 30. doi: 10.1136/bjophthalmol-2019-314906. Epub ahead of print.
45. Michaud L. Longitudinal study on ocular manifestations in a cohort of patients with Fabry disease. PLoS One 2019;14:e0213329.
46. Davies G, Dymock I, Harry J, Williams R. Deposition of melanin and iron in ocular structures in haemochromatosis. Br J Ophthalmol 1972;56:338-42.
47. Hudson JR. Ocular findings in haemochromatosis. Br J Ophthalmol. 1953;37:242-6.
48. Ustaoglu M, Solmaz N, Baser B, Kurtulgan HK, Onder F. Ocular and genetic characteristics observed in two cases of fish-eye disease. Cornea 2019;38:379-83.
49. Viestenz A, Schlotzer-Schrehardt U, Hofmann-Rummelt C, Seitz B, Kuchle M. Histopathology of corneal changes in lecithin-cholesterol acyltransferase deficiency. Cornea 2002;21:834-7.
50. Cogan DG, Kruth HS, Datilis MB, Martin N. Corneal opacity in LCAT disease. Cornea 1992;11:595-9.
51. Bron AJ. Corneal changes in the dislipoproteinaemias. Cornea 1989;8:135-40.
52. Lewis RA, Falls HF, Troyer DO. Ocular manifestations of hypercupremia associated with multiple myeloma. Arch Ophthalmol 1975;93:1050-3.
53. Silkiss RZ, Pomerleau D, Sorenson A, Vastine D, Crawford JB. Corneal cupremia in multiple myeloma: a clinicopathologic correlation. Arch Ophthalmol 2008;126:1005-6.
54. Rodrigues MM, Krachmer JH, Miller SD, Newsome DA. Posterior corneal crystalline deposits in benign monoclonal gammopathy: a clinicopathologic case report. Arch Ophthalmol 1979;97:124-8.
55. de Alba Campomanes AG, Rutar T, Crawford JB, Seiff S, Goodman D, Grenert J. Crystal-storing histiocytosis and crystalline keratopathy caused by monoclonal gammopathy of undetermined significance. Cornea 2009;28:1081-4.
56. Martin NF, Kincaid MC, Stark WJ, et al. Ocular copper deposition associated with pulmonary carcinoma, IgG monoclonal gammopathy and hypercupremia: a clinicopathologic correlation. Ophthalmology 1983;90:110-6.
57. Gjone E, Norum KR. Corneal arcus and hyperlipoproteinaemia. Lancet 1968;2:359.
58. Rifkind BM. Corneal arcus and hyperlipoproteinaemia. Surv Ophthalmol 1972;16:295-304.
59. Rennie CA, Chowdhury S, Khan J, et al. The prevalence and associated features of posterior embryotoxon in the general ophthalmic clinic. Eye (Lond) 2005;19:396-9.
60. Ozeki H, Shirai S, Majima A, Sano M, Ikeda K. Clinical evaluation of posterior embryotoxon in one institution. Jpn J Ophthalmol 1997;41:422-5.
61. Coats G. Two Cases Showing a small superficial opaque white ring in the cornea. Trans Ophthal Soc UK 1912;32:53-6.
top

Copyright ©2022. All rights reserved. Reproduction in whole or in part in any form or medium without expressed written permission of the Digital Journal of Ophthalmology is prohibited.